Clinical trial
SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction
NCT00490594 · Serica Technologies, Inc., Industry · Unknown status
Key facts
| NCT number | NCT00490594 |
|---|---|
| Title | SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction |
| Official title | A Multi-Center Open Study to Evaluate the SeriACL™ Device for Primary Anterior Cruciate Ligament Repair |
| Lead sponsor | Serica Technologies, Inc., Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Anterior Cruciate Ligament, Knee Injuries |
| Intervention type | Device |
| Interventions | ACL Reconstruction (SeriACL™ Device) |
| Enrollment | 30 |
| Start date | Jun 1, 2007 |
| Primary completion | Oct 1, 2008 |
| First posted | Jun 22, 2007 |
| Last update posted | Oct 20, 2008 |
| Countries | Germany, Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: